Clincosm LogoSign in Get a demo

hepatitis c virus infection, response to therapy of

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

Recruiting
  • Hepatitis C Virus Infection, Response to Therapy of
  • Test and treat plus peer mentors
  • Usual care
  • Birmingham, Alabama
  • +3 more
Dec 9, 2022

Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))

Completed
  • Hepatitis C
  • Hepatitis C Virus Infection, Response to Therapy of
  • glecaprevir/pibrentasvir (GLE/PIB)
  • San Diego, California
    University of California San Diego
May 23, 2022

Possible Differences in HCC Course Depending on DAA Treatment

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Direct Acting Antivirals
  • Warsaw, Mazowieckie, Poland
    Medical University of Warsaw
May 11, 2022

Viral Hepatitis B, C and HIV Among Drug Users in

Recruiting
  • Hepatitis C
  • +4 more
    • Limoges, Haute Vienne, France
      Chu Limoges
    May 3, 2022

    Hepatitis C Virus Infection, Response to Therapy of, Drug Use Trial in Belgium (Blood sampling, questionaires)

    Recruiting
    • Hepatitis C Virus Infection, Response to Therapy of
    • Drug Use
    • Blood sampling
    • questionaires
    • Antwerp, Belgium
    • +9 more
    Aug 25, 2021

    HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR

    Recruiting
    • Hepatitis C Virus Infection
    • +2 more
      • Douliu, Taiwan
      • +6 more
      Feb 23, 2021

      HCV Reinfection in HD Patients Achieving SVR

      Recruiting
      • Hepatitis C Virus Infection
      • +2 more
        • Douliu, Taiwan
        • +6 more
        Feb 22, 2021

        Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

        Withdrawn
        • Hepatitis C Virus Infection, Response to Therapy of
        • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
        • Cairo, Almanial, Egypt
          Kasr Alainy Hospital
        Apr 16, 2020

        Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus Trial in Baltimore (Usual care plus

        Completed
        Has Results
        • Hepatitis C Virus Infection, Response to Therapy of
        • Human Immunodeficiency Virus
        • Usual care plus peer-mentors
        • +2 more
        • Baltimore, Maryland
          Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
        Apr 10, 2020

        Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus Trial in Tehran (sofosbuvir and daclatasvir)

        Completed
        • Hepatitis C Virus Infection, Response to Therapy of
        • Human Immunodeficiency Virus
        • sofosbuvir and daclatasvir
        • Tehran, Iran, Islamic Republic of
        • +1 more
        Feb 19, 2019

        Hepatitis C Virus Infection, Response to Therapy of Trial in Mansourah (12 weeks (Sofosbuvir 400mg/Ledipasvir 90mg), 8 weeks

        Unknown status
        • Hepatitis C Virus Infection, Response to Therapy of
        • 12 weeks (Sofosbuvir 400mg/Ledipasvir 90mg)
        • 8 weeks (Sofosbuvir 400mg/Ledipasvir 90mg)
        • Mansourah, Dakahlia, Egypt
          Egyptian Liver Hospital
        May 23, 2018

        Hepatitis C, Chronic, Hepatitis C Virus Infection, Response to Therapy of Trial in China (Sofosbuvir, Ribavirin)

        Completed
        • Hepatitis C, Chronic
        • Hepatitis C Virus Infection, Response to Therapy of
        • Beijing, Beijing, China
        • +16 more
        Mar 5, 2018

        Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus Trial in Douliu, Taipei (Sofosbuvir and

        Completed
        • Hepatitis C Virus Infection, Response to Therapy of
        • Human Immunodeficiency Virus
        • Douliu, Taiwan
        • +1 more
        Dec 6, 2017

        Hepatitis C Virus Infection, Response to Therapy of Trial in Taipei (Personalized Physical Activity and Psycho-Education (PPAPE)

        Unknown status
        • Hepatitis C Virus Infection, Response to Therapy of
        • Personalized Physical Activity and Psycho-Education (PPAPE) Program
        • Taipei, Taiwan
          National Taiwan University Hospital
        Dec 26, 2012

        Hepatitis C Virus Infection, Response to Therapy of Trial in San Juan (JTK-853, Dose 2 JTK-853, Dose 3 JTK-853)

        Completed
        • Hepatitis C Virus Infection, Response to Therapy of
        • San Juan, Puerto Rico
          Fundacion de Investigacion de Diego
        Nov 17, 2011